Marchesini, Nicolò; Ivanov, Marcel; Lafuente Baraza, Jesus; Sala, Francesco; Foroglou, Nikos; Visocchi, Massimiliano; Olldashi, Fatos; González-López, Pablo; Rzaev, Jamil; Tisell, Magnus; Paternò, Vincenzo; Rotim, Kresimir; Timothy, Jake; Rasulic, Lukas; Demetriades, Andreas K.
(Elsevier, 2022)
Antibody-drug conjugates (ADC) are antineoplastic agents recently introduced into the antitumor arsenal. T-DM1, a trastuzumab-based ADC that relies on lysosomal processing to release the payload, is approved for HER2-positive ...